As of early 2026, Altria Group (MO) remains the undisputed titan of the United States nicotine market. However, the company is currently navigating its most significant structural shift in decades. While the iconic Marlboro brand continues to bankroll the company’s operations, Altria is aggressively pivoting toward a “smoke-free” future to combat historic declines in traditional cigarette consumption.

Marlboro remains the crown jewel of Altria’s domestic portfolio, commanding a massive 40.5% share of the total U.S. cigarette market at the close of 2025. This dominance provides the massive cash flow necessary to fund Altria’s high-yield dividends and its transition into alternative products.

Despite this leadership, the “combustible” segment faces stiff headwinds. In 2025, Altria reported a 10% decline in domestic cigarette volumes. To protect its bottom line, the company has leaned heavily on its “pricing power”—raising the cost per pack to offset the dwindling number of smokers. This strategy has kept earnings stable, but analysts watch closely as budget-conscious consumers increasingly trade down to “deep discount” brands.

The most competitive battleground for Altria is the modern oral nicotine pouch category. Its flagship brand, on!, has become a cornerstone of the company’s growth strategy. In 2025, on! shipped over 177 million cans, reflecting an 11% year-over-year increase.

However, the segment is a crowded arena. Altria currently faces intense pressure from Philip Morris International’s ZYN, which dominates the category. To regain momentum, Altria is currently rolling out on! PLUS. This next-generation product features a premium “spitless” design and improved mouthfeel, recently receiving critical FDA marketing orders for several variants in early 2026. This launch is seen as a pivotal moment for Altria to capture the “premium” pouch segment.

Altria continues to be a favorite for income-focused investors, maintaining its status as a “Dividend King” with 56 consecutive years of dividend increases. For 2026, the company forecast an adjusted diluted EPS of $5.56 to $5.72, signaling steady, single-digit growth.

The company is also preparing for a major cultural shift. Long-time CEO Billy Gifford is set to retire in May 2026, with current CFO Sal Mancuso slated to take the helm. Mancuso will inherit a company that is no longer just a “cigarette company” but a diversified nicotine business.

The path for Altria in 2026 involves balancing the decline of its legacy tobacco business with the rapid scaling of its “Moving tobacconbeverage Beyond Smoking” vision. Success will depend on whether on! PLUS can successfully erode ZYN’s market share and how effectively the company integrates its NJOY e-vapor products into a cohesive, smoke-free ecosystem.

Would you like to examine the latest market share data comparing Altria’s on! pouches against its top competitor, ZYN?